Microchimerism, GVHD, and tolerance in solid organ transplantation

Transfusion

Volumn 41, Issue 3, 2001, Pages 419-426

  Triulzi, Darrell J ^a,b   Nalesnik, Michael A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BLOOD TRANSFUSION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; MICROCHIMERISM; ORGAN DONOR; ORGAN TRANSPLANTATION; REVIEW; T LYMPHOCYTE;

CELL TRANSPLANTATION; CHIMERA; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; ORGAN TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY;

EID: 0035086771     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41030419.x     Document Type: Review

References (68)

1. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver
2. Cell migration, chimerism, and graft acceptance
3. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
4. Graft versus host disease
5. The biology of graft-versus-host reactions
6. Transfusion associated graft-vs-host disease
7. Red cell antibodies arising from solid organ transplants
8. Transfusion support in solid-organ transplantation
9. Graft-versus-host disease in solid organ transplantation
10. Severe graft-versus-host disease in a liver-transplant recipient
11. Fatal generalized acute graft-versus-host disease in a liver transplant recipient
12. Successful small-bowel/liver transplantation
13. Graft vs. host disease after liver transplantation in humans: A report of four cases
14. Graft-versus-host disease in a liver transplant recipient
15. Graft-versus-host disease and liver transplantation
16. Brief report: Donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient
17. Clinical and pathological features of graft-versus-host disease after liver transplantation: A case report and review of the literature
18. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing
19. Graft-versus-host disease after liver transplantation
20. Immunologic monitoring of graft-versus-host disease following orthotopic liver transplantation
21. Fatal graft-versus-host-disease: A grave complication after orthotopic liver transplantation
22. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation
23. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers
24. Reversal of graft-versus-host disease with infusion of autologous bone marrow
25. Lethal acute graft-versus-host disease in a liver transplant recipient: Relations with cell migration and chimerism
26. Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient
27. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: Report of a case and literature review
28. High-dose donor bone marrow infusions to enhance allograft survival
29. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood
30. Successful treatment of graft-vs-host disease after a second liver transplant
31. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions
32. Graft-versus-host disease after orthotopic liver transplantation in a child
33. Survival of graft-versus-host disease in a liver transplant recipient
34. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor
35. Graft-versus-host disease after liver and small bowel transplantation in a child
36. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of Cell and whole organ transplantation from Lewis to Brown Norway rats
37. Immunologic, clinical, and pathologic aspects of human graft-versus-host disease
38. Immune cholangitis: Liver allograft rejection and graft-versus-host disease
39. Brief report: Graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors
40. Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation
41. A case of chronic graft-versus-host disease following living-related donor kidney transplantation
42. Transfusion-associated graft-versus-graft and potential graft-versus-host disease in a renal allotransplanted patient
43. Transfusion-associated graft-versus-host disease in a renal transplant recipient
44. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient
45. Graft-versus-host-like disease in a heart allograft recipient
46. Pseudo-graft-versus-host disease in heart and heart-lung recipients
47. Graft versus host disease after human heart-lung transplantation
48. Pancreaticoduodenal transplantation in humans
49. Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation
50. Lethal graft-versus-host disease in a recipient of a pancreas-spleen transplant
51. Clinical intestinal transplantation: New perspectives and immunologic considerations
52. Graft versus host disease (GVHD) in intestinal allograft recipients
53. Chimerism and thoracic organ transplantation
54. Cellular basis of long-term organ transplant acceptance: Pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance
55. T cell receptor gene diversity and selection
56. Organ-specific unresponsiveness induced by intrathymic injection of donor bone marrow cells and a short course of immunosuppression in the rat heart transplantation model
57. The human bone marrow as an immunoregulatory organ
58. Microchimerism in bone marrow-derived CD34+ cells of patients after liver transplantation
59. Augumentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells
60. A clinical trial combining donor bone marrow infusion and heart transplantation: Intermediate-term results
61. Infusion of donor leukocyres to induce tolerance in organ allograft recipients
62. Liver from bone marrow in humans
63. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism
64. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts
65. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
66. Microchimerism: Inaccurate literature citations
67. Graft persistence effectively induces and maintains donor-specific unresponsiveness
68. Microchimerism and hyporesponsiveness induced by intraportal injection of donor spleen cells in rats